Publication | Closed Access
Sensitization of Non-small Cell Lung Cancer Cells to Cisplatin by Naturally Occurring Isothiocyanates
45
Citations
17
References
2010
Year
Oncogenic AgentMedicinePeitc Deplete Beta-tubulinPharmacologyNaturally Occurring IsothiocyanatesBronchial NeoplasmMicrom Benzyl IsothiocyanateCancer BiologyPhenethyl IsothiocyanateAnti-cancer AgentCancer TreatmentLung CancerRadiation OncologyOncologyCell BiologyTumor MicroenvironmentCancer Research
We show that naturally occurring isothiocyanates (ITCs) sensitize human non-small cell lung cancer cells to cisplatin. Moreover, the structure of the ITC side chain moiety is important for sensitization. In NCI-H596 cells, 20 microM benzyl isothiocyanate (BITC) and phenethyl isothiocyanate (PEITC) enhance the efficacy of various concentrations of cisplatin, but sulforaphane (SFN) does not. Reducing the concentration of BITC and PEITC to 10 microM still allows for the sensitization of cells to cisplatin. Neither cellular platinum accumulation nor DNA platination account for this increased cytotoxicity. BITC and PEITC deplete beta-tubulin, but SFN does not; this correlates with and may be important for sensitization.
| Year | Citations | |
|---|---|---|
Page 1
Page 1